Challenges in Shelf Life Assignment for Biologics and Biosimilars
Unlike small molecule drugs, biologics and biosimilars present complex structural and stability challenges that make assigning a reliable shelf life far more intricate. These large molecules are sensitive to environmental conditions, degradation pathways, and formulation changes—all of which directly impact product efficacy and safety over time. This tutorial explores the technical, regulatory, and practical obstacles…
Read More “Challenges in Shelf Life Assignment for Biologics and Biosimilars” »